Raburn M. Mallory

6.5k total citations
33 papers, 863 citations indexed

About

Raburn M. Mallory is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Raburn M. Mallory has authored 33 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Raburn M. Mallory's work include Influenza Virus Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Respiratory viral infections research (15 papers). Raburn M. Mallory is often cited by papers focused on Influenza Virus Research Studies (17 papers), SARS-CoV-2 and COVID-19 Research (16 papers) and Respiratory viral infections research (15 papers). Raburn M. Mallory collaborates with scholars based in United States, Sweden and Japan. Raburn M. Mallory's co-authors include Christopher S. Ambrose, Harlan M. Krumholz, Cary P. Gross, Filip Dubovsky, Taff Jones, Hervé Caspard, Xionghua Wu, Tingting Yi, Jing Yu and Harry L. Malech and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Raburn M. Mallory

28 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Raburn M. Mallory United States	15	435	330	202	118	85	33	863
Patrick Lacor Belgium	20	219 0.5×	319 1.0×	165 0.8×	203 1.7×	53 0.6×	67	1.3k
Muki Shey South Africa	17	358 0.8×	453 1.4×	288 1.4×	73 0.6×	121 1.4×	55	948
Fiona Guerra Canada	10	398 0.9×	239 0.7×	187 0.9×	55 0.5×	189 2.2×	15	822
Amy C Sherman United States	12	475 1.1×	352 1.1×	131 0.6×	106 0.9×	42 0.5×	41	908
Praveen Dhankhar United States	10	433 1.0×	223 0.7×	55 0.3×	159 1.3×	68 0.8×	18	859
Saied Ghorbani Iran	13	178 0.4×	486 1.5×	88 0.4×	138 1.2×	160 1.9×	49	1.0k
Andrew J. Dunning United States	14	1.1k 2.5×	366 1.1×	324 1.6×	122 1.0×	220 2.6×	19	1.3k
Victoria Landolfi United States	14	956 2.2×	324 1.0×	280 1.4×	116 1.0×	223 2.6×	20	1.2k
Allison August United States	15	349 0.8×	239 0.7×	104 0.5×	146 1.2×	21 0.2×	20	717
Ahmed R. Alsuwaidi United Arab Emirates	15	248 0.6×	262 0.8×	60 0.3×	39 0.3×	149 1.8×	46	627

Countries citing papers authored by Raburn M. Mallory

Since Specialization

Citations

This map shows the geographic impact of Raburn M. Mallory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raburn M. Mallory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raburn M. Mallory more than expected).

Fields of papers citing papers by Raburn M. Mallory

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raburn M. Mallory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raburn M. Mallory. The network helps show where Raburn M. Mallory may publish in the future.

Co-authorship network of co-authors of Raburn M. Mallory

This figure shows the co-authorship network connecting the top 25 collaborators of Raburn M. Mallory. A scholar is included among the top collaborators of Raburn M. Mallory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raburn M. Mallory. Raburn M. Mallory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Áñez, Germán, Wayne Woo, Karen L. Kotloff, et al.. (2025). Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine. 61. 127362–127362.

Kotloff, Karen L., R. Scott McClelland, Joyce S. Plested, et al.. (2025). Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study. The Lancet Infectious Diseases. 25(5). 585–594. 5 indexed citations

Plested, Joyce S., Raj Kalkeri, Katherine Clegg Smith, et al.. (2025). Immunogenicity and safety of a monovalent Omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine in previously unvaccinated, SARS-CoV-2 seropositive participants: Primary day-28 analysis of a phase 2/3 open-label study. Vaccine. 55. 127046–127046.

Plested, Joyce S., Raj Kalkeri, MingZhu Zhu, et al.. (2025). Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial. Vaccine. 73. 128164–128164.

Plested, Joyce S., Gordon Chau, Shane Cloney-Clark, et al.. (2023). Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373. Vaccine. 41(29). 4280–4286. 12 indexed citations

Dunkle, Lisa M., Shabir A. Madhi, Cynthia L. Gay, et al.. (2023). Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine. Expert Review of Vaccines. 22(1). 501–517. 20 indexed citations

Patel, Nita, Jessica F. Trost, Mimi Guebre‐Xabier, et al.. (2023). XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants. Scientific Reports. 13(1). 19176–19176. 36 indexed citations

Formica, Neil, Raburn M. Mallory, Gary Albert, et al.. (2021). Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial. PLoS Medicine. 18(10). e1003769–e1003769. 64 indexed citations

Mallory, Raburn M., et al.. (2020). A systematic review and meta-analysis of the effectiveness of LAIV4 and IIV in children aged 6 months to 17 years during the 2016–2017 season. Vaccine. 38(18). 3405–3410. 8 indexed citations

10.

Mallory, Raburn M., Andrew C. Nyborg, Rubana N. Kalyani, et al.. (2019). A study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24–<48 months of age. Vaccine. 38(5). 1001–1008. 9 indexed citations

11.

Zeitlin, Pamela L., Mila A. Leong, Jeremy Cole, et al.. (2018). Benralizumab does not impair antibody response to seasonal influenza vaccination in adolescent and young adult patients with moderate to severe asthma: results from the Phase IIIb ALIZE trial. Journal of Asthma and Allergy. Volume 11. 181–192. 28 indexed citations

12.

Caspard, Hervé, Raburn M. Mallory, Jing Yu, & Christopher S. Ambrose. (2017). Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015–2016: A Systematic Review and Meta-Analysis. Open Forum Infectious Diseases. 4(3). ofx111–ofx111. 56 indexed citations

13.

Caspard, Hervé, Kathleen Coelingh, Raburn M. Mallory, & Christopher S. Ambrose. (2016). Association of vaccine handling conditions with effectiveness of live attenuated influenza vaccine against H1N1pdm09 viruses in the United States. Vaccine. 34(42). 5066–5072. 33 indexed citations

14.

Matsuoka, Yumiko, Sinthujan Jegaskanda, Theresa Fitzgerald, et al.. (2015). Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). The Journal of Infectious Diseases. 213(6). 922–929. 43 indexed citations

15.

Sheldon, Eric, Robert Jeanfreau, Joseph Sliman, et al.. (2012). Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study*. Influenza and Other Respiratory Viruses. 7(6). 1142–1150. 13 indexed citations

16.

Ambrose, Christopher S., Xionghua Wu, Taff Jones, & Raburn M. Mallory. (2012). The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine. 30(48). 6794–6801. 90 indexed citations

17.

Mallory, Raburn M., Tingting Yi, & Christopher S. Ambrose. (2011). Shedding of Ann Arbor strain live attenuated influenza vaccine virus in children 6–59 months of age. Vaccine. 29(26). 4322–4327. 32 indexed citations

18.

Mallory, Raburn M., Elissa Malkin, Christopher S. Ambrose, et al.. (2010). Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. PLoS ONE. 5(10). e13755–e13755. 48 indexed citations

19.

Brown, Bruce K., Josephine H. Cox, Thomas C. VanCott, et al.. (2010). Phase I Study of Safety and Immunogenicity of an Escherichia coli-Derived Recombinant Protective Antigen (rPA) Vaccine to Prevent Anthrax in Adults. PLoS ONE. 5(11). e13849–e13849. 28 indexed citations

20.

Sekhsaria, Sudhir, et al.. (1993). Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.. Proceedings of the National Academy of Sciences. 90(16). 7446–7450. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact